Align Technology, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0162551016
USD
168.49
-5.27 (-3.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DexCom, Inc.
IDEXX Laboratories, Inc.
Medtronic Plc
Edwards Lifesciences Corp.
Agilent Technologies, Inc.
Align Technology, Inc.
Zimmer Biomet Holdings, Inc.
West Pharmaceutical Services, Inc.
GE Healthcare Technologies, Inc.
Becton, Dickinson & Co.
Mettler-Toledo International, Inc.

Why is Align Technology, Inc. ?

1
High Management Efficiency with a high ROE of 12.95%
2
The company is Net-Debt Free
3
Poor long term growth as Operating profit has grown by an annual rate 11.97% of over the last 5 years
4
Positive results in Mar 26
  • NET PROFIT(HY) At USD 329.41 MM has Grown at 58.55%
  • INVENTORY TURNOVER RATIO(HY) Highest at 5.25 times
  • RAW MATERIAL COST(Y) Fallen by -2.92% (YoY)
5
With ROE of 13.05%, it has a attractive valuation with a 2.93 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -4.42%, its profits have risen by 19.6% ; the PEG ratio of the company is 0.9
6
Rising Promoter Confidence
  • Promoters have increased their stake in the company by 0.53% over the previous quarter and currently hold 0.89% of the company
  • Promoters increasing their stake is a sign of high confidence in the future of the business
7
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -4.42% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Align Technology, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Align Technology, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Align Technology, Inc.
-8.14%
-0.60
53.85%
S&P 500
22.24%
1.91
13.23%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
10.30%
EBIT Growth (5y)
11.97%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.02
Tax Ratio
30.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
25.44%
ROE (avg)
12.95%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.93
EV to EBIT
15.84
EV to EBITDA
12.68
EV to Capital Employed
3.62
EV to Sales
2.68
PEG Ratio
0.92
Dividend Yield
NA
ROCE (Latest)
22.82%
ROE (Latest)
13.05%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(HY)

At USD 329.41 MM has Grown at 58.55%

INVENTORY TURNOVER RATIO(HY)

Highest at 5.25 times

RAW MATERIAL COST(Y)

Fallen by -2.92% (YoY

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Align Technology, Inc.

Net Profit
At USD 329.41 MM has Grown at 58.55%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 5.25 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -2.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 56.55 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation
At USD 56.55 MM has Grown at 63.93%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)